Zydus receives USFDA approval for Diltiazem Hydrochloride Tablets in multiple strengths
Approval covers 30 mg, 60 mg, 90 mg, and 120 mg tablets for the management of chronic stable angina and angina due to coronary…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AbbVie’s upadacitinib holds potential to cement dominant place in alopecia areata with latest…
Phase III UP-AA trial data show higher response rates than current JAK inhibitors, positioning AbbVie’s upadacitinib as a…
Lupin launches Glucagon for injection USP in the United States
Product indicated for severe hypoglycaemia treatment and as a diagnostic aid during radiologic procedures in adults
Can we reduce plastics usage in pharmaceutical industry? – Think
Dr Ashok Omray highlights the widespread use of single-use plastics in pharma manufacturing and calls for scientific solutions to…
Zydus Lifesciences receives Health Canada approval for smoking cessation drug
Zydus Lifesciences secures Notice of Compliance for ZDS-Varenicline tablets in Canada, expanding its footprint in the North…
QRL Bioscience raises ₹3 crore from GVFL to advance regenerative therapies
Funding will support clinical trials for DFU treatment and preclinical development of osteoarthritis therapy
Industry experts weigh in on US tariff exemption for Indian pharma amid section 232 review
The US administration has excluded Indian pharma exports from immediate tariff hikes. Industry leaders highlight the importance of…
Sun Pharma introduces Volini Uparna for Warkaris during Pandharpur Yatra
Volini Uparna integrates pain relief gel into traditional cloth to support pilgrims on 250-km journey
ENTOD Pharmaceuticals launches Myopia therapy and collagen serum in new R&D push
ENTOD Pharmaceuticals announces new treatments in ophthalmology and dermatology as part of its India-first innovation strategy,…
Intas Pharmaceuticals and Accord BioPharma expand global pegfilgrastim footprint with UDENYCA…
Acquisition from Coherus BioSciences positions Accord BioPharma as a key global player in biosimilar pegfilgrastim market